Full Approval of Pfizer COVID-19 Vaccine Could Come in September
The U.S. Food and Drug Administration is speeding up its timetable for full approval of the Pfizer coronavirus vaccine.
COVID19 Vaccine
WHO Slams COVID-19 Booster Shots in Wealthy Nations
Wealthy nations should not be giving COVID-19 vaccine booster shots to their citizens while poor nations struggle to get first doses of vaccines.
Report: Moderna Vaccine’s Protection Does Not Wane After 6 Months
Moderna Inc. announced on Thursday that the potency of its vaccine does not dim in the first six months after the second dose.
Antibody Levels High With COVID-19 Vaccination for Previously Infected
SARS-CoV-2 antibody levels are higher in previously infected individuals than in infection-naive individuals after one dose of the BNT162b2 vaccine.
Racial/Ethnic Disparities Persist in Adult Vaccination Coverage
Racial and ethnic disparities in vaccine coverage persisted over the last decade among adults aged 65 years and older.
Most With Reaction to mRNA COVID-19 Vaccine Tolerate Second Dose
Most patients with an immediate and potentially allergic reaction to the first dose of the Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate a second dose.
Pfizer Says Third Shot of Vaccine Boosts COVID-19 Protection
New data show that protection from both doses of the Pfizer COVID-19 vaccine decreases slightly over time.
Pfizer, Moderna to Expand Vaccine Studies in Young Children
Pfizer and Moderna are expanding trials of their COVID-19 vaccines in children ages 5 to 11 years to more closely measure the risk for heart inflammation.
Post-Vaccination Breakthrough SARS-CoV-2 Infections Enriched for Variants of Concern
The researchers examined SARS-CoV-2 genomes isolated from individuals believed to have experienced vaccine breakthrough and compared them to the background of SARS-CoV-2 sequences from Washington State over the same time period.
CDC Advisers to Discuss Third COVID-19 Vaccine Dose for Immunocompromised
Giving a third dose of COVID-19 vaccines to immunocompromised adults will be up for discussion during a US Centers for Disease Control and Prevention advisory panel meeting next week.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...